Kalendář akcí

17.10.2017

Zasedání Učené společnosti

2. část: zajišťuje I. sekce věd matematicko-fyzikálních

21.11.2017

Zasedání Učené společnosti

2. část: zajišťuje II. sekce věd chemických

28.11.2017

Veřejná přednáška ze série přednášek Františka Palackého

Zajišťuje IV. sekce věd společenských a humanitních Přednášku pronese prof. Christoph Markschies (Humboldt-Universität zu Berlin)

Nadační fond

Raška Karel

Jr., Prof., M.D., Ph.D., F.C.A.P.
Born May 26, 1939 in Prague

  • Honorary member of Learned Society since 2003

Educational and professional preparation

  • 1956, graduate, 14th eleven-year secondary school, Prague;
  • 1956-1962, Third Faculty of Medicine, Charles University (CU);
  • 1962, MUDr.; post-graduate student, Institute of Organic Chemistry and Biochemistry, Czechoslovak Academy of Sciences (CSAS);
  • 1965, CSc.,
  • 1965-1966, postdoctoral fellow, Yale University School of Medicine, New Haven, Connecticut (USA);
  • 1966-1967, research associate, Rutgers University, New Brunswick, New Jersey (USA);
  • 1973-1976, resident in pathology, Rutgers Medical School, Piscataway, New Jersey;
  • professional certificates: Educational Commission for Foreign Medical Graduates (ECFMG), FLEX (flexible spending accounts), American Board of Pathology: anatomic and clinical, immuno-pathology, medical licences: New Jersey, New York, Maine; bioanalytical laboratory director license: New Jersey.

Employment and academic positions

  • 1967-1968, scientist, Institute of Organic Chemistry and Biochemistry, CSAS;
  • 1968-1971, Assistant Professor, Rutgers Medical School;
  • 1969, Professor, Graduate Faculty, Rutgers University;
  • 1971-1976, Associate Professor, Rutgers Medical School;
  • 1976-1986, Professor, Rutgers Medical School;
  • 1986, Professor, Robert Wood Johnson Medical School;
  • 1989-1992, Head, Department of Laboratory Medicine and Pathology, University of Medicine and Dentistry, New Jersey (UMDNJ)-New Jersey Medical School, Newark, New Jersey (USA);
  • 1989-1992, Head, Department of Experimental Pathology, UMDNJ-Graduate School of Biomedical Sciences, Newark;
  • 1992, Head, Department of Laboratory Medicine and Pathology, St. Peter’s University Hospital, New Brunswick;
  • 1992, Head, Institute for Molecular Diagnostics and Pathology, New Brunswick
  • 2004, Professor of Pathology, Drexel University College of Medicine, Philadelphia, Pa (USA)

Membership in domestic scientific bodies (selection)

  • 1994, Foreign (honorary) member, Scientific Council, FMP, CU

Membership and positions in international organizations and societies

  • 1970, American Society for Investigative Pathology
  • 1970, American Society for Microbiology
  • 1976, American Association of Immunologists
  • 1976, American Society for Cell Biology
  • 1976, American Association for Cancer Research
  • 1976, New Jersey Society of Pathologists
  • 1976, International Academy of Pathology
  • 1976, Society for Experimental Biology and Medicine
  • 1982, College of American Pathologists
  • 1982, American Society for Virology
  • 1984, Association of University Pathologists (Pluto club); President 1986, 1989, 1994
  • 1989, Sigma-Xi
  • 1994, Czechoslovak Society of Arts and Sciences, Washington,DC (USA), 2004 Vice-President, 2006-2012 President

Editorial boards

  • 1986-1993, Proceedings of the Society for Experimental Biology and Medicine
  • 1987, Experimental Therapeutics
  • 1985-1992, Member, Special Review Committees, The National Institutes of Health, Bethesda, Maryland (USA) (National Eye Institute, National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases)
  • 1985-1988, New Jersey State Department of Health Advisory Committee on HIV testing
  • 1989-1994, New Jersey State Department of Health Advisory Committee on Laboratory Standardization
  • 1984-1987, 1996, Executive Council, Robert Wood Johnson Medical School
  • 1989-1992, Faculty Council, New Jersey, Medical School
  • 1991-2001, Board of Trustees, New Jersey Organ and Tissue Sharing Network
  • 1992, Executive Committee, St. Peter´s University Hospital
  • 1993, Advisory Board, Cancer Institute of New Jersey

Notable awards

  • 1966, Award, CSAS (for study of 5-azacytidine)
  • 1965, Fellowship, Commonwealth Fund, New York (USA)
  • 1976, 1978, 1982, „Best teacher“, Rutgers Medical School
  • 1993, Honorary Professor of Molecular Biology, Third Faculty of Medicine, CU
  • 1995, 1998, 2002, 2004, elected to „Best Doctors in America“
  • 1995, 1998, 2002, 2004-2012, elected to "Best Doctors in America"
  • 2009, Prize of the Society of Arts and Sciences, Prague
  • 2010, Silver Medal of the senate of the parliament of the Czech republic
  • 2010, Medal of Merit, Ist Grade, in Science, Czech republic

Selected publications

  • K. Raška, Jr., D. Frohwirth, R. W. Schlesinger: Transfer RNA in KB Cells Infected with Adenovirus Type 2. J. Virol. 5, 464, (1970)
  • J. E. Zimmerman, K. Raška, Jr.: Inhibition of adenovirus Type 12 Induced DNA Synthesis in G1 Arrested BHK21 Cells by Dibutyryl Adenosine Cyclic 3': 5'-Monophosphate. Nature New Biology 239, 145 (1972)
  • K. K. Biron, K. Raška, Jr.: Purification of Adenovirus Type 12 Tumor Antigen from Transformed Hamster Cells. Virology 76, 516 (1977)
  • K. Raška, Jr., A. B. Morrison, J. Rašková: Humoral inhibitors of the Immune Response in Uremia. II. Immunosuppressive Factor of Uremic Rat Serum is a Very Low Density Lipoprotein. Laboratory Investigation 42, 636 (1980)
  • K. Raška, Jr., P. H. Gallimore: an Inverse Relation of the oncogenic Potential of Adenovirus Transformed Cells and Their Sensitivity to Killing by Syngeneic Natural Killer Cells. Virology 123, 8 (1982)
  • K. Raška, Jr., J. Rašková et al: T Cell Subsets and Cellular immunity in End Stage Renal Disease. Amer J. Med. 75: 734 (1983)
  • Y. Sawada, D. Urbanelli, J. Rašková, T. E. Shenk, K. Raška, Jr.: Adenovirus Tumor-Specific Transplantion Antigen is a Function of the E1A Early Region. J. Exp. Med. 163, 563 (1986)
  • K. Raška, Jr., et al.: Human Immunodeficiency Virus Infection in Hemophiliacs: Long-Term Prognostic Significance of the HIV Serologic Pattern. Clin. Exp. Immunol. 77, 1 (1989)
  • R. Javier, K. Raška, Jr., T. Shenk: Requirement for the Adenovirus Type 9 E4 Region in Production of Mammary Tumors. Science 257, 1267 (1992)
  • K. Raška, Jr.: Functional Domains of Adenovirus E1A Oncogenes which Control Interactions with Effectors of Cellular Immunity. Current Topics Microbiol. and Immunol. 199/III, 131 (1995)

Zpět na seznam článků

Novinky

07.09.17

Profesor Pavel Hobza obdržel prestižní Schrödingerovu medaili

Člen Učené společnosti prof. Pavel Hobza převzal 30. srpna 2017 Schrödingerovu medaili, nejvyšší ocenění od Světové organizace teoretických chemiků WATOC. Toto významné ocenění obdržel za svou excelentní práci o nekovalentních interakcích. Z jeho úspěchů je přitom známý zejména objev nepravé vodíkové vazby. Pavel Hobza také prokázal, že patrové interakce řízené jedním typem nekovalentních interakcí, tzv. disperzní energie, jsou zodpovědné za strukturu DNA.

17.05.17

Prohlášení k sídlu Středoevropské univerzity

Prohlášení k sídlu Středoevropské univerzity (PDF, 74 kB)

15.05.17

XXIII. Valné shromáždění Učené společnosti České republiky 15.–16. 5. 2017

Učená společnost pořádala ve dnech 15. 5. a 16. 5. 2017 své XXIII. valné shromáždění. Na slavnostní části v Karolinu 15. 5. 2017 udělila medaile a ceny Učené společnosti (PDF, 79 kB).